Gastroesophageal reflux disease (GERD), which develops when stomach acid frequently flows back into the esophagus, is common in long-term care residents. Similar to other conditions, older adults are at a higher risk of complications from chronic GERD, making it important for long-term care providers—including LTC pharmacy services—to stay up to date on the condition. Some common medications used to treat GERD in residents include antacids, histamine 2-receptor antagonists, and proton pump inhibitors. While these medications are readily available and effective at relieving symptoms, there are a number of lifestyle modifications that can also help. Many of these modifications can be used in conjunction with medications to provide residents with optimal outcomes. [Tweet “#GERD is a common medical condition in older adults, including #SkilledNursing Facility residents.”]
LTC Pharmacy Notes: Lifestyle Changes for Treating GERD
Before resorting to pharmacologic treatment, it’s wise to see if certain lifestyle modifications help improve GERD symptoms in skilled nursing residents. There are two particular lifestyle modifications with the strongest amount of evidence: weight loss and head-of-bed elevation. Though weight loss may not be the answer for residents—who are at increased risk of nutritional deficiencies—long-term care providers can reduce GERD symptoms in residents by simply elevating the resident’s head using foam blocks or an extra pillow. In addition, a handful of other lifestyle changes that can help with GERD include:- restricting food intake two to three hours before bed
- avoiding spicy foods
- limiting foods with high fat content
LTC Pharmacy Notes: Medications for Treating GERD
Pharmacologic options do have their place in the treatment of GERD. However, it’s important that they be used as a preventive measure, rather than a responsive one. GERD medications are designed to reduce the acidity of the stomach. There are three primary categories of medications for treating GERD:- antacids
- histamine 2-receptor antagonists (H2RAs)
- proton pump inhibitors (PPIs)
- CBC abnormalities
- liver function irregularities
- headaches
- Clostridium difficile-associated diarrhea
- pneumonia
- bone fractures
- rebound hypersecretion
- hypomagnesemia
- vitamin B12 deficiency
- drug interactions